`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PROLLENIUM US INC.,
`Petitioner
`
`v.
`
`ALLERGAN INDUSTRIE, SAS,
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`IPR2019-01505, Patent 8,450,475 B2
`IPR2019-01506, Patent 8,357,795 B2
`IPR2019-01508, Patent 9,238,013 B2
`IPR2019-01509, Patent 9,358,322 B2
`IPR2019-01617, Patent 8,822,676 B2
`IPR2019-01632, Patent 8,357,795 B2
`IPR2020-00084, Patent 9,089,519 B2
`
`
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER ALLERGAN INDUSTRIE, SAS’S
`UNOPPOSED MOTION FOR PRO HAC VICE ADMISSION
`UNDER 37 C.F.R. § 42.10(c)
`
`
`
`
`
`
`
`
`Attorney Docket: 13551-0081IP1
`
`
`Exhibit No.
`2001
`2002
`2003
`2004
`
`2005
`2006
`2007
`2008
`2009
`2010
`2011
`
`EXHIBITS
`
`Exhibit Description
`Juvéderm Ultra™ XC Label
`Juvéderm Ultra Plus™ XC Label
`Juvéderm Voluma®XC Label
`U.S. Patent Publication No. 2004/0101959 to Marko et al,
`published May 27, 2004
`Excerpts from U.S. 8,822,676 file history
`Excerpts from U.S. 9,089,519 file history
`About Juvéderm Ultra Plus™ XC
`About Juvéderm Volbella® XC
`About Juvéderm Voluma® XC
`RESERVED
`Declaration in support of unopposed motion for pro hac vice
`admission of Elizabeth Flanagan
`
`i
`
`
`
`Attorney Docket: 13551-0081IP1
`
`
`
`Pursuant to 37 C.F.R. § 42.10(c), the Patent Owner (“Allergan Industrie,
`
`SAS”) respectfully requests that the Board recognize Elizabeth M. Flanagan as
`
`counsel pro hac vice in this proceeding. Patent Owner seeks the counsel of
`
`Elizabeth M. Flanagan due to her experience in representing Allergan Industrie,
`
`SAS in other patent-related matters and particularly due to her familiarity with the
`
`substantive and technical issues involved in these proceedings. This motion is
`
`authorized by the Notice of Filing Date Accorded to Petition and Time for Filing
`
`Patent Owner Preliminary Response that was mailed on September 19, 2019.
`
`Patent Owner conferred with Petitioner, and Petitioner confirmed on June 2, 2020
`
`that it does not oppose this motion.
`
`Where the lead counsel is a registered practitioner, a non-registered
`
`practitioner may be permitted to appear pro hac vice “upon a showing that counsel
`
`is an experienced litigating attorney and has established familiarity with the subject
`
`matter at issue in the proceeding.” 37 C.F.R. § 42.10(c); Unified Patents, Inc. v.
`
`Parallel Iron, LLC, Case IPR2013-00639 (PTAB Oct. 15, 2013) (Paper 7) (setting
`
`forth requirements for pro hac vice admission). As set forth in her declaration
`
`submitted herewith (Exhibit 2011), Ms. Flanagan is a Principal at Fish &
`
`Richardson P.C. and a patent litigation attorney with significant experience
`
`advising clients regarding patent matters, including as counsel in litigation. More
`
`specifically, Ms. Flanagan has represented Patent Owner in district court litigation
`
`1
`
`
`
`Attorney Docket: 13551-0081IP1
`
`involving two of the six patents at issue in these IPR proceedings, U.S. Patent Nos.
`
`8,357,795 and 8,450,475. Based on this underlying litigation and the other facts
`
`detailed below and in her declaration, Ms. Flanagan has significant familiarity with
`
`the particular subject matter in this IPR proceeding. Additionally, Ms. Flanagan
`
`concurrently applying to appear pro hac vice in all captioned cases.
`
`Statement of Facts
`
`Ms. Flanagan is a patent litigation attorney with more than 11 years of
`
`experience representing clients in cases involving pharmaceuticals and medical
`
`devices. Ms. Flanagan regularly litigates patent cases before various federal
`
`district courts and in the United States Court of Appeals for the Federal Circuit.
`
`Through her practice in such cases, Ms. Flanagan has gained substantial experience
`
`in jury trials, bench trials, discovery, Markman hearings, and appeals. Allergan
`
`Industrie, SAS provides Exhibit A, as evidence, Elizabeth M. Flanagan’s
`
`biography.
`
`Ms. Flanagan also has particular experience and familiarity with the
`
`substantive and technical issues involved in this inter partes review proceeding.
`
`Ms. Flanagan served as counsel for Allergan Industrie, SAS in district court
`
`litigation over U.S. Patent Nos. 8,357,795, which is at issue in IPR2019-01506 and
`
`IPR2019-01632, and U.S. Patent No. 8,450,475, which is at issue in IPR2019-
`
`01505. That litigation, Allergan USA, Inc. and Allergan Industrie, SAS v. Medicis
`
`2
`
`
`
`Attorney Docket: 13551-0081IP1
`
`Aesthetics Inc., et al., Case No. SACV 13-1436 AG (JPRx) (C.D. Cal.), settled
`
`during the course of expert discovery. In that case, Ms. Flanagan participated in
`
`many phases of the litigation, including fact discovery, expert discovery, and claim
`
`construction proceedings. Through her representation in this related matter,
`
`Allergan Industrie, SAS has developed a particular relationship with Ms. Flanagan
`
`such that it desires to continue that relationship for the purpose of these
`
`proceedings.
`
`Declaration of Individual Seeking to Appear
`
`This Motion for Pro Hac Vice Admission is accompanied by a Declaration
`
`of Elizabeth M. Flanagan as required by the Order Authorizing Motion for Pro
`
`Hac Vice mailed September 19, 2019. As Ms. Flanagan stated in her
`
`accompanying Declaration, she has read, will comply with, and agrees to be
`
`subject to the Office Patent Trial Practice Guide and the Board’s Rules of Practice
`
`for Trials set forth in part 42 of the Code of Federal Regulations. As also set forth
`
`in her Declaration, Ms. Flanagan is a member in good standing of the Bars of the
`
`State of Minnesota, Delaware, and Michigan, and is admitted to practice in
`
`numerous federal courts.
`
`Accordingly, Allergan Industrie, SAS submits that there is good cause under
`
`37 C.F.R. § 42.10(c) for the Board to recognize Elizabeth M. Flanagan as counsel
`
`pro hac vice during these proceedings.
`
`3
`
`
`
`Attorney Docket: 13551-0081IP1
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Dorothy P. Whelan/
`Dorothy P. Whelan
`Reg. No. 33,814
`Counsel for Patent Owner
`
`
`
`
`
`
`Date: June 8, 2020
`
`
`Customer Number 26171
`Fish & Richardson P.C.
`Telephone: (612) 337-2508
`Facsimile: (612) 288-9696
`
`4
`
`
`
`Attorney Docket: 13551-0081IP1
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4) and 42.6(e)(4)(iii), the undersigned
`
`certifies that on June 8, 2020, a complete and entire copy of this Unopposed
`
`Motion for Pro Hac Vice Admission with supporting exhibit were provided via
`
`electronic service, to the Petitioner by serving the correspondence address of
`
`record as follows:
`
`Christopher L. Curfman
`William W. Cutchins
`Meunier Carlin & Curfman LLC
`999 Peachtree St, NE
`Suite 1300
`Atlanta, GA 30309
`Email:
`ccurfman@mcciplaw.com
`wcutchins@mcciplaw.com
`mcc.prollenium.ipr@mcciplaw.com
`
`
`
`
`/Jessica K. Detko/
`Jessica K. Detko
`Fish & Richardson P.C.
`60 South Sixth Street, Suite 3200
`Minneapolis, MN 55402
`(612) 337-2516
`
`
`5
`
`